Global Complexity Demands Local Resilience

Global trade dynamics are reshaping how biotech and pharmaceutical companies think about where and how medicines are developed and manufactured. As supply chain risks evolve, many companies are looking to strengthen resilience, reduce dependence on overseas networks, and build more regionally aligned manufacturing strategies.

At Thermo Fisher Scientific, we’re making significant, long-term investments across our U.S. network to help customers navigate these challenges. Our growing footprint of development and manufacturing sites is designed to strengthen domestic supply of critical medicines across a broad range of modalities and platforms.

With integrated capabilities spanning early development through commercial manufacturing, our U.S. network helps customers build greater supply chain resilience, navigate uncertainty, and create a more reliable path to market.

Watch the video to see how our connected U.S. capabilities can help minimize disruption, strengthen supply chain resilience, and keep your programs moving forward.